通过调节铁亡,GSTP1抑制了血管酶II诱导的心房动
Han Li1,2, Zhenyu Feng1, Benke Li3
1Institute of Cardiovascular Diseases and department of Hematology, The First Affiliated Hospital of Dalian Medical University, Lianhe Road 193, Dalian 116000, People's Republic of China.
概括
谷氨-S-转移酶pi 1 (GSTP1) 通过调节铁死来保护抗血管素II诱导的心房动. 较低的GSTP1水平与心房相关,恢复GSTP1提供了一个潜在的治疗策略.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 心房动是一种常见的心律失常,与中风和死亡风险增加有关.
- 谷氨-S转移酶pi 1 (GSTP1) 是一个关键的铁灭调节剂,参与细胞保护.
- GSTP1在血管素II诱导的心房动中的作用仍然没有被阐明.
研究的目的:
- 调查GSTP1在血管新素II诱导的心房的作用和机制.
- 在心房重塑的背景下,探索GSTP1在铁亡途径中的参与.
主要方法:
- 开发了一种小鼠心房动模型,使用血管激素II.
- 利用蛋白质组学和铁性PCR阵列来识别关键的分子因素.
- 在干预研究中使用铁灭抑制剂 (Ferrostatin-1),AAV9介导的GSTP1过度表达和GSTP1抑制剂 (Ezatiostat).
主要成果:
- 蛋白质组学揭示了在心房动中铁亡途径的显著变化.
- 用Ferrostatin-1抑制ferroptosis改善了血管激素II诱导的心房动.
- 在心房的模型,细胞和人体组织中,GSTP1的表达显著下降.
- 通过AAV9-cTNT-GSTP1过度表达抑制了心房动,心肌损伤,氧化应激和铁.
结论:
- 通过GSTP1介导的铁亡在血管素II诱导的心房动中起着关键作用.
- GSTP1成为治疗心房动的潜在治疗标.
更多相关视频
相关概念视频
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
566
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
566
01:21G-Protein Gated Ion Channels
4.5K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
4.5K
01:09GPCRs Regulate Adenylyl Cylase Activity
5.1K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.1K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
360
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
360
01:25Antihypertensive Drugs: Direct Renin Inhibitors
468
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
468
01:20The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K